PATENT CLAIM ANALYSIS

Application Number: 16078155
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2019-02
Patent Classification: ["514", "249000"]

Abstract:
Compounds of formula (I) wherein A, R, W, Q, n and m have the meaning according to the claims can be employed, inter alia, for the treatment of tauopathies and Alzheimer's disease.

Claim (Index 2):
A compound chosen from the group consisting of formula Ia and Ib: wherein A, R, W, Q, n and m have the meaning given in  claim 1 .

Metadata:
- Claim Count in Document: 23.0
- Percentile: 96.0
- Lexical Diversity: 1.27273
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['14502213', '14131471', '14775134', '15830675', '13515598']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8281482016214549
- 35 USC 102 Novelty (BERT): 0.5408280836584468
- Combined Prediction Score: 0.799416189825154
- Mean Citation Score: 355.667998
- Max Citation Score: 387.89282
- Similarity Product: 260.4702703749549

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test